Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06671639 · ClinicalTrials.gov registry record · NA

Stanford Program to Accelerate Robotic Children's Surgery

A NA study, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
250
Enrollment target

NCT06671639: Recruiting NA study, sponsored by Stanford University.

NCT06671639 is a NA study that is actively recruiting participants, run by Stanford University. The registered enrollment target is 250 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06671639, a NA study, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target

Study Summary

The goal of this clinical trial is to provide additional data to confirm safety and performance of the da Vinci Xi Surgical System in a human clinical setting. This pilot study is intended to provide an initial assessment to evaluate the feasibility, safety, and effectiveness for the utilization of the da Vinci Xi on pediatric and adolescent patients. This clinical trial will be conducted under the auspices of Stanford University's IRB approval.

Primary Outcome

Performance defined as the conversion to an open approach required to complete the procedure

Interventions

  • DEVICE da Vinci Xi Robotic Surgery System

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2025-08-01
Est. Completion 2028-02-28
Phase NA
Stanford University

1,744 total trials

What NCT06671639 shows while recruiting

NCT06671639 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).

The record links to 0 conditions, and to 1 intervention - of which da Vinci Xi Robotic Surgery System is the first listed.

NCT06671639 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06671639 about?

NCT06671639 is a clinical study titled "Stanford Program to Accelerate Robotic Children's Surgery". The goal of this clinical trial is to provide additional data to confirm safety and performance of the da Vinci Xi Surgical System in a human clinical setting. This pilot study is intended to provide an initial assessment to evaluate the feasibility, safety, and effectiveness for the utilization of ...

What is the current status of trial NCT06671639?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2025-08-01. Estimated completion is 2028-02-28.

What interventions are being tested in trial NCT06671639?

The interventions under investigation include: da Vinci Xi Robotic Surgery System (DEVICE).

Who is sponsoring clinical trial NCT06671639?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06671639's enrollment target sits among peer trials

250 410th of 2000 higher than 1,567 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06671639, the US trial registry maintained by the National Library of Medicine. NCT06671639 (mid enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.